The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

Automated insulin delivery systems have demonstrated benefits for patients with type 1 diabetes, yet their efficacy and safety for individuals with type 2 diabetes remain less established. Prior ...

NovoPen ®, the first insulin pen injector ... studies of NovoPen ® devices (NovoPen ® [1], NovoPen ® 2, NovoPen ® 1.5 and NovoPen ® 3) in the diabetes/insulin therapy area that contained ...

Otherwise known as an artificial pancreas or closed-loop system, an automated insulin delivery (AID) system is a technology that helps people with type 1 diabetes manage their blood sugar levels by ...

Novo Nordisk has made its smart insulin pens available in the UK ... According to Novo Nordisk, people living with type 1 (insulin-dependent) diabetes saw a reduction in time spent in ...

In Type 1 diabetes, the immune system mistakes the body’s healthy cells for foreign ones and tries to fight them. In this case, the immune system attacks and destroys the insulin-producing beta ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

CBSE allows students with Type 1 diabetes to carry insulin pumps and glucometers, highlighting the need for paediatric ...

In type 1 diabetes, the immune system attacks the beta cells that produce insulin in your pancreas. The attack causes permanent damage and leaves your pancreas unable to produce insulin.

But the clinical trials of these medications specifically excluded people with type 1 diabetes, who are dependent on the hormone insulin to survive because they can’t make enough of their own.

Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed from randomized, controlled trials regarding their role in the ...